ArticleBMC pregnancy and childbirth2026
Comparison between oral dydrogesterone versus no drugs in clinical outcome within the natural cycle-frozen-thawed embryo transfer cycle: a retrospective analysis.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis retrospective study aimed to compare the live birth rate and clinical pregnancy rate in natural cycle-frozen-thawed embryo transfer (NC-FET) with oral dydrogesterone as luteal phase support or without any drugs.
methodRetrospective, cohort study. Totally 2657 NC-FET cycles allocated to two groups from the reproductive medical center at the University of Hong Kong-Shenzhen hospital from 2015 to 2023 and the Center of Reproductive Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine using data in 2023. One group of NC-FET cycles (n = 1160) used oral dydrogesterone as LPS, the other group (n = 1497) use no drugs.
resultsSignificant differences were found in woman's age, antral follicle account, E2 level on the day of Luteinizing hormone surge, the number of transferred embryo and the secondary infertility before propensity score matching (PSM). Thus 802 cycles in each group remained after PSM. Then no significant differences were found in each characteristic between two groups. No significant differences in live birth rate (27.930% vs. 32.173%, P = 0.064), clinical pregnancy rate (33.416% vs. 38.030%, P = 0.054), implantation rate (27.322% vs. 29.636%, P = 0.229), and miscarriage rate (16.418% vs. 15.635%, P = 0.798) were found between the control group and the study group after PSM.
conclusion30 mg/d oral dydrogesterone and no LPS revealed similar reproductive outcomes in NC-FET cycles in the study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.